Leonard M. Greenstein, Chief Financial Officer at Tarsus Pharmaceuticals, Inc. (TARS), sold 1,004 shares at $12.89 ($13K) on 2023-03-21, disclosed to the SEC on 2023-03-23.
Open-market sale of $13k TARS by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $12.89 | 326 | $4K | 33.3% |
| 2 | $12.64 | 332 | $4K | 33.3% |
| 3 | $12.15 | 346 | $4K | 33.4% |
| Total | $12.55 avg | 1,004 | $13K | 100% |
| Filing → |
| TARS | SELL | 2023-03-17 | $71K | — | Filing → |
| TARS | SELL | 2023-02-17 | $76K | — | Filing → |
| TARS | SELL | 2023-01-20 | $73K | — | Filing → |